TIGIT-Fc alleviates acute graft-versus-host disease by suppressing CTL activation via promoting the generation of immunoregulatory dendritic cells.

Zhang D, Hu W, Xie J, Zhang Y, Zhou B, Liu X, Zhang Y, Su Y, Jin B, Guo S, et al. TIGIT-Fc alleviates acute graft-versus-host disease by suppressing CTL activation via promoting the generation of immunoregulatory dendritic cells. Biochim Biophys Acta. 2018.